X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (23499) 23499
Newspaper Article (1064) 1064
Magazine Article (106) 106
Trade Publication Article (62) 62
Book Chapter (49) 49
Book / eBook (27) 27
Dissertation (24) 24
Conference Proceeding (13) 13
Government Document (5) 5
Newsletter (5) 5
Web Resource (5) 5
Book Review (3) 3
Publication (2) 2
Reference (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (14964) 14964
retina (13095) 13095
humans (7971) 7971
ophthalmology (7769) 7769
retina - drug effects (7279) 7279
male (6562) 6562
female (4950) 4950
rats (4592) 4592
retina - metabolism (4447) 4447
neurosciences (4438) 4438
retina - pathology (3313) 3313
mice (3261) 3261
eye diseases (2848) 2848
retina - cytology (2788) 2788
diabetic retinopathy (2676) 2676
macular degeneration (2658) 2658
sense organs (2654) 2654
retina - physiology (2509) 2509
middle aged (2363) 2363
genetic structures (2089) 2089
cells, cultured (2042) 2042
apoptosis (2034) 2034
aged (1987) 1987
electroretinography (1972) 1972
expression (1962) 1962
diabetes (1929) 1929
adult (1924) 1924
rabbits (1893) 1893
biochemistry & molecular biology (1822) 1822
research (1752) 1752
multidisciplinary sciences (1731) 1731
disease models, animal (1721) 1721
analysis (1675) 1675
research article (1674) 1674
photoreceptors (1670) 1670
vascular endothelial growth factor (1645) 1645
retinopathy (1633) 1633
light (1631) 1631
proteins (1623) 1623
eye (1587) 1587
time factors (1557) 1557
oxidative stress (1536) 1536
medicine (1531) 1531
cell biology (1530) 1530
dose-response relationship, drug (1523) 1523
mice, inbred c57bl (1443) 1443
in vitro techniques (1420) 1420
neurons (1416) 1416
rats, sprague-dawley (1408) 1408
glaucoma (1322) 1322
physiological aspects (1315) 1315
cells (1276) 1276
retinal ganglion cells - drug effects (1263) 1263
inflammation (1246) 1246
age (1238) 1238
tomography, optical coherence (1233) 1233
immunohistochemistry (1185) 1185
gene expression (1179) 1179
science (1161) 1161
patients (1140) 1140
intravitreal injections (1128) 1128
rodents (1125) 1125
studies (1113) 1113
physiology (1112) 1112
rat retina (1105) 1105
endothelial growth-factor (1095) 1095
care and treatment (1091) 1091
pharmacology & pharmacy (1058) 1058
visual acuity (1038) 1038
edema (1036) 1036
retina - physiopathology (1008) 1008
fluorescein angiography (995) 995
angiogenesis (992) 992
disease (967) 967
activation (956) 956
optical coherence tomography (934) 934
brain (932) 932
diabetes mellitus (928) 928
degeneration (922) 922
medicine, research & experimental (904) 904
ganglion-cells (902) 902
treatment outcome (899) 899
biology (897) 897
photic stimulation (894) 894
signal transduction (889) 889
surgery (885) 885
ischemia (869) 869
medicine & public health (858) 858
neuroprotection (858) 858
injections (850) 850
neurons - drug effects (839) 839
chick embryo (834) 834
aged, 80 and over (833) 833
retinal degeneration (832) 832
health aspects (806) 806
retinal ganglion cells (805) 805
bevacizumab (804) 804
in-vivo (804) 804
follow-up studies (803) 803
inhibition (802) 802
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (24124) 24124
Japanese (266) 266
German (221) 221
Russian (136) 136
French (109) 109
Chinese (99) 99
Polish (54) 54
Italian (38) 38
Portuguese (38) 38
Spanish (28) 28
Hungarian (8) 8
Dutch (5) 5
Turkish (5) 5
Czech (4) 4
Romanian (3) 3
Danish (2) 2
Korean (2) 2
Slovak (2) 2
Swedish (2) 2
Finnish (1) 1
Hebrew (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 02/2012, Volume 7, Issue 2, p. e31650
CHARGE syndrome is caused by mutations in the CHD7 gene. Several organ systems including the retina, cranial nerves, inner ear and heart are affected in CHARGE... 
INNER-EAR | GENE | RETINAL LAMINATION | MULTIDISCIPLINARY SCIENCES | CRANIAL NERVE ABNORMALITIES | MUTATIONS | NEURAL CREST | EXPRESSION | ASSOCIATION | PHENOTYPIC SPECTRUM | N-CADHERIN | Body Patterning - drug effects | Retina - drug effects | Neovascularization, Physiologic - drug effects | Face - innervation | Heart - embryology | Retina - embryology | Spine - drug effects | RNA, Messenger - metabolism | Zebrafish - embryology | Gene Knockdown Techniques | DNA-Binding Proteins - metabolism | Otolithic Membrane - embryology | Motor Neurons - cytology | Spine - embryology | Cell Polarity - drug effects | Otolithic Membrane - drug effects | DNA Helicases - genetics | Skull - drug effects | Motor Neurons - drug effects | Disease Models, Animal | Calcification, Physiologic - drug effects | Zebrafish Proteins - metabolism | Morpholinos - administration & dosage | RNA, Messenger - genetics | Embryonic Development - genetics | Gene Expression Regulation, Developmental - drug effects | Axons - drug effects | DNA-Binding Proteins - genetics | Zebrafish - genetics | Neural Crest - drug effects | Skull - embryology | DNA Helicases - metabolism | Injections | Animals | CHARGE Syndrome - metabolism | Neural Crest - embryology | Zebrafish - metabolism | Morpholinos - pharmacology | Retina - abnormalities | Heart - drug effects | CHARGE Syndrome - genetics | Zebrafish Proteins - genetics | Embryonic Development - drug effects | Body Patterning - genetics | Somites - drug effects | Embryonic development | Genetic aspects | Heart | Segmentation | Pathogenesis | Genomics | Retina | Hybridization | Inner ear | Defects | Charge simulation | Morphogenesis | Organismal biology | Reduction | Mineralization | Nerves | Polarity | Fish | Vagus nerve | Chromosomes | Motor neurons | Vertebrae | Neurons | Retinal cells | Zebrafish | RNA polymerase | Dentistry | Gene expression | Clustering | Retinal ganglion cells | Hospitals | Cranial nerves | CHARGE syndrome | Photoreceptors | Skull | Mutation | Aberration | Curvature | Binding sites
Journal Article
Development (Cambridge), ISSN 0950-1991, 11/2013, Volume 140, Issue 22, pp. 4510 - 4521
Muller glia function as retinal stem cells in adult zebrafish. In response to loss of retinal neurons, Muller glia partially dedifferentiate, re-express... 
Müller glia | N-cadherin | Retinal regeneration | Alcama | Muller glia | STEM-CELLS | DEDIFFERENTIATION | PROLIFERATION | DEVELOPMENTAL BIOLOGY | GOLDFISH RETINA | ADULT ZEBRAFISH | VERTEBRATE RETINA | ROD PHOTORECEPTORS | SIGNALING PATHWAY | NEUROGENESIS | LINEAGE | Cadherins - metabolism | Multipotent Stem Cells - metabolism | Photoreceptor Cells, Vertebrate - drug effects | Ependymoglial Cells - metabolism | Neural Stem Cells - cytology | Neuroepithelial Cells - cytology | Retinal Ganglion Cells - metabolism | Retinal Neurons - cytology | Retinal Ganglion Cells - cytology | Neurogenesis - drug effects | Retinal Neurons - drug effects | Asymmetric Cell Division - drug effects | Ouabain - pharmacology | Biomarkers - metabolism | Cell Dedifferentiation - drug effects | Zebrafish Proteins - metabolism | Neural Stem Cells - drug effects | Photoreceptor Cells, Vertebrate - cytology | Cell Adhesion - drug effects | Ependymoglial Cells - drug effects | Regeneration - drug effects | Animals | Retinal Neurons - metabolism | Models, Biological | Multipotent Stem Cells - cytology | Zebrafish - metabolism | Ependymoglial Cells - cytology | Heterozygote | Neuroepithelial Cells - metabolism | Photoreceptor Cells, Vertebrate - metabolism | Cell Cycle - drug effects | Neural Stem Cells - metabolism | Retinal Ganglion Cells - drug effects | Stem Cells and Regeneration
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 09/2015, Volume 35, Issue 39, pp. 13336 - 13350
Journal Article
PloS one, ISSN 1932-6203, 2014, Volume 9, Issue 1, p. e84800
.... The aim of our present study was to investigate whether the protective effect of LBP after I/R damage was mediated via activation of the Nrf2/HO-1-antioxidant pathway in the retina... 
CELLS | CARBON-MONOXIDE | INDUCED OXIDATIVE STRESS | MULTIDISCIPLINARY SCIENCES | IN-VIVO | CAPILLARY DEGENERATION | GENE-EXPRESSION | INJURY | HEME OXYGENASE-1 | GLUCOSE DEPRIVATION | FREE-RADICALS | Amacrine Cells - drug effects | Retina - drug effects | Heme Oxygenase-1 - metabolism | Retina - metabolism | Reactive Oxygen Species - metabolism | Apoptosis - drug effects | Amacrine Cells - metabolism | Drugs, Chinese Herbal - pharmacology | Male | Retinal Ganglion Cells - metabolism | Retinal Ganglion Cells - pathology | Heme Oxygenase-1 - genetics | Cell Nucleus - metabolism | Disease Models, Animal | Reperfusion Injury | Rats | Enzyme Activation - drug effects | Protein Transport | Gene Expression Regulation - drug effects | Animals | Signal Transduction - drug effects | NF-E2-Related Factor 2 - metabolism | Oxidative Stress - drug effects | Retina - pathology | Lycium - chemistry | Retinal Ganglion Cells - drug effects | Antioxidants | Polysaccharides | Nervous system diseases | Ischemia | Analysis | Heme | Health aspects | Glaucoma | Oxidative stress | Neuroprotection | Diabetic retinopathy | Neurosciences | Transcription factors | Laboratories | Retina | Alcohol | Activation | Kinases | Western blotting | Embryology | Reperfusion | Protoporphyrin | Education | Rodents | Aging | Carbon monoxide | Damage | Saccharides | Medical research | Enzymes | Cell survival | Neurodegenerative diseases | Heme oxygenase (decyclizing) | Gene expression | Zinc | Neurological diseases | Medicine | Studies | Oxygenase | Brain research | Inhibitors | Visual impairment | Immunofluorescence | Mercury | Apoptosis | Intraocular pressure | Animal cognition
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2009, Volume 361, Issue 1, pp. 40 - 51
This study aimed to determine whether early administration of drugs that block the renin... 
MEDICINE, GENERAL & INTERNAL | STRUCTURAL-FUNCTIONAL RELATIONSHIPS | CORTICAL INTERSTITIUM | BLOOD-PRESSURE CONTROL | EARLY NATURAL-HISTORY | RETINOPATHY | RECEPTOR | ANGIOTENSIN-CONVERTING ENZYME | NEPHROPATHY | PROGRESSION | ENDOTHELIAL GROWTH-FACTOR | Retina - drug effects | Angiotensin II Type 1 Receptor Blockers - adverse effects | Follow-Up Studies | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Male | Albuminuria | Angiotensin II Type 1 Receptor Blockers - pharmacology | Enalapril - therapeutic use | Enalapril - adverse effects | Mesangial Cells - drug effects | Glomerular Filtration Rate - drug effects | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Adult | Female | Angiotensin-Converting Enzyme Inhibitors - pharmacology | Diabetic Nephropathies - prevention & control | Double-Blind Method | Diabetes Mellitus, Type 1 - physiopathology | Kidney Glomerulus - drug effects | Diabetes Mellitus, Type 1 - pathology | Kaplan-Meier Estimate | Losartan - pharmacology | Logistic Models | Kidney Glomerulus - pathology | Disease Progression | Diabetes Mellitus, Type 1 - drug therapy | Diabetic Retinopathy - prevention & control | Enalapril - pharmacology | Losartan - therapeutic use | Mesangial Cells - pathology | Losartan - adverse effects | Renin-Angiotensin System - drug effects | Retina - pathology | Diabetic retinopathy | Control | Usage | Enalapril | Type 1 diabetes | Patient outcomes | Losartan | Enalaprilat | Drug therapy | Kidneys | Diabetes | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Diabetes (New York, N.Y.), ISSN 1939-327X, 2018, Volume 67, Issue 9, pp. 1867 - 1879
Intermittent fasting (IF) protects against the development of metabolic diseases and cancer, but whether it can prevent diabetic microvascular complications is... 
DIABETIC-RETINOPATHY | BILE-ACID | CELLS | ACTIVATION | BACTERIA | OBESITY | METABOLISM | FARNESOID X RECEPTOR | C57BL/6 MICE | ENDOCRINOLOGY & METABOLISM | TAUROURSODEOXYCHOLIC ACID | Retina - drug effects | Leukocytes - pathology | Receptors, G-Protein-Coupled - metabolism | Colon - drug effects | Microvessels - metabolism | Microvessels - pathology | Colon - immunology | Male | Ganglia, Sensory - metabolism | Retina - immunology | Intestinal Mucosa - drug effects | Diabetic Retinopathy - complications | Retinal Vessels - pathology | Feces - microbiology | Intestinal Mucosa - immunology | Bacteroidetes - isolation & purification | Firmicutes - growth & development | Diabetic Retinopathy - immunology | Firmicutes - isolation & purification | Retinal Vessels - metabolism | Colon - pathology | Retinal Vessels - drug effects | Dysbiosis - therapy | Goblet Cells - metabolism | Colon - metabolism | Ganglia, Sensory - pathology | Diabetic Retinopathy - prevention & control | Gastrointestinal Microbiome - drug effects | Bile Acids and Salts - therapeutic use | Survival Analysis | Leukocytes - drug effects | Diabetes Mellitus, Type 2 - pathology | Dysbiosis - pathology | Retina - pathology | Intestinal Mucosa - pathology | Intestinal Mucosa - metabolism | Retina - metabolism | Diabetes Mellitus, Type 2 - microbiology | Ganglia, Sensory - drug effects | Goblet Cells - drug effects | Diabetic Retinopathy - pathology | Receptors, G-Protein-Coupled - agonists | Dysbiosis - microbiology | Microvessels - immunology | Ganglia, Sensory - immunology | Goblet Cells - immunology | Leukocytes - immunology | Retinal Vessels - immunology | Mice, Mutant Strains | Diabetes Mellitus, Type 2 - therapy | Bacteroidetes - immunology | Mice, Inbred DBA | Verrucomicrobia - growth & development | Verrucomicrobia - immunology | Diabetes Mellitus, Type 2 - complications | Fasting | Microvessels - drug effects | Firmicutes - immunology | Verrucomicrobia - isolation & purification | Dysbiosis - complications | Animals | Bacteroidetes - growth & development | Gastrointestinal Microbiome - immunology | Goblet Cells - pathology | Prevention | Diabetic retinopathy | Usage | Diet therapy | Low-calorie diet | Rattus | Rats | Health aspects | Complications | 0107
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 0027-8424, 5/2010, Volume 107, Issue 19, pp. 8599 - 8604
Structural features of neurons create challenges for effective production and distribution of essential metabolic energy. We investigated how metabolic energy... 
Mitochondria | Energy metabolism | Neurons | Synaptic transmission | Antibodies | Retina | Photoreceptors | Creatine | Pipettes | Synapses | Phototransduction | ROD CELLS | MITOCHONDRIAL | PHOTORECEPTOR | MULTIDISCIPLINARY SCIENCES | phototransduction | DEFICIENCY | CREATINE-KINASE-B | METABOLISM | ADAPTATION | MAGNETIC-RESONANCE | energy metabolism | SALAMANDER RETINA | BRAIN | Retina - drug effects | Darkness | Mitochondria - enzymology | Retinal Photoreceptor Cell Outer Segment - metabolism | Glutamates - metabolism | Retinal Photoreceptor Cell Outer Segment - radiation effects | Presynaptic Terminals - radiation effects | Urodela - physiology | Retinal Vessels - enzymology | Presynaptic Terminals - enzymology | Retinal Photoreceptor Cell Outer Segment - drug effects | Retinal Cone Photoreceptor Cells - enzymology | Retina - enzymology | Energy Metabolism - radiation effects | Mitochondria - radiation effects | Synaptic Transmission - drug effects | Energy Metabolism - physiology | Creatine Kinase - antagonists & inhibitors | Electroretinography | Retina - radiation effects | Retinal Cone Photoreceptor Cells - radiation effects | Presynaptic Terminals - drug effects | Retinal Vessels - drug effects | Mitochondria - drug effects | Retina - physiology | Animals | Dinitrofluorobenzene - pharmacology | Synaptic Transmission - radiation effects | Models, Biological | Retinal Cone Photoreceptor Cells - cytology | Creatine Kinase - metabolism | Retinal Cone Photoreceptor Cells - drug effects | Mice | Protein Kinase Inhibitors - pharmacology | Retinal Vessels - radiation effects | Energy Metabolism - drug effects | Bioenergetics | Physiological aspects | Neural transmission | Research | Biological Sciences | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Oftalmologi | Ophthalmology | Klinisk medicin
Journal Article
Molecular vision, ISSN 1090-0535, 2009, Volume 15, Issue 278-81, pp. 2634 - 2648
Journal Article
Journal of cell science, ISSN 1477-9137, 2018, Volume 131, Issue 3, pp. jcs210492 - jcs210492
Journal Article
Diabetes, ISSN 0012-1797, 10/2010, Volume 59, Issue 10, pp. 2637 - 2645
.... We investigated the molecular and cellular mechanisms underlying the protective effects of CaD against the increase in blood-retinal barrier (BRB... 
CONTROLLED CLINICAL-TRIAL | ACTIVATION | ENDOCRINOLOGY & METABOLISM | DOUBLE-BLIND | OCCLUDIN | RETINOPATHY | GROWTH-FACTOR | BARRIER BREAKDOWN | VASCULAR-PERMEABILITY | EXPRESSION | ANTIOXIDANT PROPERTIES | Retina - drug effects | Phosphoproteins - drug effects | Rats, Wistar | Hemostatics - pharmacology | Male | Leukocytes - physiology | Phosphoproteins - metabolism | Occludin | Diabetic Retinopathy - physiopathology | Tight Junctions - physiology | Blood-Brain Barrier - physiology | Membrane Proteins - metabolism | Endothelial Cells - physiology | Diabetes Mellitus, Experimental - physiopathology | Tight Junctions - drug effects | Permeability - drug effects | Retina - physiopathology | Rats | Claudin-5 | Cell Adhesion - drug effects | Blood-Brain Barrier - drug effects | Diabetic Retinopathy - metabolism | Retina - physiology | Endothelium - drug effects | Diabetic Retinopathy - prevention & control | Animals | Zonula Occludens-1 Protein | Cell Adhesion - physiology | Endothelial Cells - cytology | Membrane Proteins - drug effects | Leukocytes - drug effects | Calcium Dobesilate - pharmacology | Endothelium - physiology | Endothelial Cells - drug effects | Junctional complexes (Epithelium) | Calcium, Dietary | Cell adhesion | Cell junctions | Development and progression | Leukocytes | Diabetes | Properties | Observations | Health aspects | Endothelium | Complications
Journal Article
PloS one, ISSN 1932-6203, 2011, Volume 6, Issue 7, p. e22514
Acute primary open angle glaucoma is an optic neuropathy characterized by the elevation of intraocular pressure, which causes retinal ischemia and neuronal... 
APOPTOSIS | OXIDATIVE STRESS | MULTIDISCIPLINARY SCIENCES | FOCAL CEREBRAL-ISCHEMIA | IN-VIVO | GANGLION-CELL DEATH | CHICK-EMBRYOS | ACID-PHOSPHATASE | ENDOCYTOSIS | DYING NEURONS | SELF-DIGESTION | Retina - drug effects | Neurons - pathology | Retina - metabolism | Intraocular Pressure - drug effects | Rats, Wistar | Apoptosis - drug effects | Microtubule-Associated Proteins - metabolism | Cell Count | Astrocytes - pathology | Caspase 3 - metabolism | Male | Autophagy - drug effects | Retinal Ganglion Cells - pathology | Acid Phosphatase - metabolism | Lysosomes - metabolism | Neuroprotective Agents - pharmacology | Time Factors | Drug Design | Neurons - metabolism | Neurons - drug effects | Reperfusion Injury - metabolism | Lysosomes - drug effects | Astrocytes - drug effects | Adenine - analogs & derivatives | Reperfusion Injury - pathology | Endocytosis - drug effects | Retina - physiopathology | Rats | Adenine - pharmacology | Animals | Reperfusion Injury - prevention & control | Reperfusion Injury - physiopathology | Retina - pathology | Retinal Ganglion Cells - drug effects | Glaucoma | Dextran | Phosphatases | Research | Ischemia | Neurons | Diabetic retinopathy | Neurosciences | Optic neuropathy | Fluorescence | Phagosomes | Horseradish peroxidase | Retina | Labelling | Activation | Neuropathy | Kinases | Phosphatase | Autophagy | Endocytosis | Reperfusion | Gangrene | Peroxidase | Trends | Hypertension | Mortality | Markers | Pharmacology | Pressure | Acids | Cell death | Photoreceptors | Death | Immunoreactivity | Immunofluorescence | Acid phosphatase | Histochemistry | Phagocytosis | Apoptosis | Intraocular pressure
Journal Article